Cargando…
Nanotechnological Strategies for Protein Delivery
The use of therapeutic proteins plays a fundamental role in the treatment of numerous diseases. The low physico-chemical stability of proteins in physiological conditions put their function at risk in the human body until they reach their target. Moreover, several proteins are unable to cross the ce...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100203/ https://www.ncbi.nlm.nih.gov/pubmed/29693640 http://dx.doi.org/10.3390/molecules23051008 |
_version_ | 1783348822236200960 |
---|---|
author | Villegas, María Rocío Baeza, Alejandro Vallet-Regí, María |
author_facet | Villegas, María Rocío Baeza, Alejandro Vallet-Regí, María |
author_sort | Villegas, María Rocío |
collection | PubMed |
description | The use of therapeutic proteins plays a fundamental role in the treatment of numerous diseases. The low physico-chemical stability of proteins in physiological conditions put their function at risk in the human body until they reach their target. Moreover, several proteins are unable to cross the cell membrane. All these facts strongly hinder their therapeutic effect. Nanomedicine has emerged as a powerful tool which can provide solutions to solve these limitations and improve the efficacy of treatments based on protein administration. This review discusses the advantages and limitations of different types of strategies employed for protein delivery, such as PEGylation, transport within liposomes or inorganic nanoparticles or their in situ encapsulation. |
format | Online Article Text |
id | pubmed-6100203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61002032018-11-13 Nanotechnological Strategies for Protein Delivery Villegas, María Rocío Baeza, Alejandro Vallet-Regí, María Molecules Review The use of therapeutic proteins plays a fundamental role in the treatment of numerous diseases. The low physico-chemical stability of proteins in physiological conditions put their function at risk in the human body until they reach their target. Moreover, several proteins are unable to cross the cell membrane. All these facts strongly hinder their therapeutic effect. Nanomedicine has emerged as a powerful tool which can provide solutions to solve these limitations and improve the efficacy of treatments based on protein administration. This review discusses the advantages and limitations of different types of strategies employed for protein delivery, such as PEGylation, transport within liposomes or inorganic nanoparticles or their in situ encapsulation. MDPI 2018-04-25 /pmc/articles/PMC6100203/ /pubmed/29693640 http://dx.doi.org/10.3390/molecules23051008 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Villegas, María Rocío Baeza, Alejandro Vallet-Regí, María Nanotechnological Strategies for Protein Delivery |
title | Nanotechnological Strategies for Protein Delivery |
title_full | Nanotechnological Strategies for Protein Delivery |
title_fullStr | Nanotechnological Strategies for Protein Delivery |
title_full_unstemmed | Nanotechnological Strategies for Protein Delivery |
title_short | Nanotechnological Strategies for Protein Delivery |
title_sort | nanotechnological strategies for protein delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100203/ https://www.ncbi.nlm.nih.gov/pubmed/29693640 http://dx.doi.org/10.3390/molecules23051008 |
work_keys_str_mv | AT villegasmariarocio nanotechnologicalstrategiesforproteindelivery AT baezaalejandro nanotechnologicalstrategiesforproteindelivery AT valletregimaria nanotechnologicalstrategiesforproteindelivery |